IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL
NCT05136924
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
OC-01 (varenicline 1.2mg/ml) nasal spray vs Placebo
OTHER:
Placebo (vehicle) nasal spray
Sponsor
Vance Thompson Vision - MT